Acne Light Therapy Wand

K160691 · Zuko, Inc. · OLP · Jun 21, 2016 · General, Plastic Surgery

Device Facts

• Record ID: K160691
• Device Name: Acne Light Therapy Wand
• Applicant: Zuko, Inc.
• Product Code: OLP · General, Plastic Surgery
• Decision Date: Jun 21, 2016
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 878.4810
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Acne Light Therapy Wand is indicated to treat mild to moderate inflammatory acne.

Device Story

Hand-held, battery-powered LED light therapy device; emits blue (442nm) and red (633nm) light; no UV emission. User-operated by placing device over treatment area and pressing 'On' button; automatic shut-off after treatment cycle. Used in home setting by patients. Provides non-invasive light therapy to treat inflammatory acne; intended to reduce acne severity through light exposure.

Clinical Evidence

No clinical data. Substantial equivalence established via non-clinical bench testing, including electrical safety (IEC 60601-1), electromagnetic compatibility (IEC 60601-1-2), and photobiological safety (IEC 62471). A self-selection and usability study confirmed the device is easy to use and labeling is appropriate for laypersons.

Technological Characteristics

Hand-held, battery-powered (1 AAA alkaline). Materials: Polypropylene, Polycarbonate, Aluminum. Wavelengths: 442±4nm (blue) and 633±4nm (red). Treatment area: 1.594 cm². Total dose rate: 34.0 mW/cm². Total dose: 12.2 J/cm². Standards: IEC 60601-1, IEC 60601-1-2, IEC 62471.

Indications for Use

Indicated for patients with mild to moderate inflammatory acne.

Regulatory Classification

Identification

(1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.

Predicate Devices

• Tanda Zap Mini Skincare System (K124042)
• LightStim for Acne (K142246)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an emblem that features a stylized caduceus, a symbol often associated with medicine and healthcare. The caduceus is composed of three intertwined lines, representing the three branches of government.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

June 21, 2016

Zuko, Inc. % Ms. M. Joyce Heinrich President Texas Applied Biomedical Services (T.A.B.S.) 12101 Cullen Blvd, Suite A Houston, Texas 77047

Re: K160691 Trade/Device Name: Acne Light Therapy Wand Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: OLP Dated: May 16, 2016 Received: May 19, 2016

Dear Ms. Heinrich:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Jennifer R. Stevenson -A

For Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K160691

Device Name Acne Light Therapy Wand

Indications for Use (Describe)

The Acne Light Therapy Wand is indicated to treat mild to moderate inflammatory acne.

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Texas Applied Biomedical Services (T.A.B.S.) Traditional 510(k) Premarket Submission Model: Acne Light Therapy Wand

### 510(k) Summary for Acne Light Therapy Wand

#### 1. Submission Sponsor

Zuko, Inc.

### 2. Submission Correspondent

Texas Applied Biomedical Services (T.A.B.S.) 12101 Cullen Blvd, Suite A Houston, Texas 77047 Phone: [phone] Fax: [phone] Contact: M. Joyce Heinrich, President Email: [e-mail]

### 3. Date Prepared

17 June 2016

### 4. Device Name

Trade/Proprietary Name: Acne Light Therapy Wand Common/Usual Name: Acne Light Therapy System Classification Name: Over-the-counter powered light based laser for acne Classification Regulation: 21CFR 878.4810 Classification Panel: General and Plastic Surgery Product Code: OLP Device Class: II FDA Establishment Registration #: To be obtained after clearance

#### 5. Predicate Devices

- Tanda Zap Mini Skincare System 510(k) number K124042, cleared on April 02, 2013, manufactured by Syneron Beauty Inc.
- LightStim for Acne 510(k) number K142246, cleared on January 29, 2015, manufactured by LED Intellectual Properties, LLC
- 6. Device Description

⁴ NOTE: OLP is the best description and closest match to this device. However the device uses LED light sources; there is no coherent (laser) light involved.

{4}------------------------------------------------

The Acne Light Therapy Wand uses known LED light therapy technology for the treatment of acne. A combination of blue light and red light is emitted. The Acne Light Therapy Wand device does not emit any ultraviolet (UV) light. UV light is defined as light with the range of 100-400nm. To use the Acne Light Therapy Wand device, users place the device over the treatment area and press the "On" button on the device to start treatment. The device will automatically turn off after each treatment cycle.

## 7. Intended Use

The Acne Light Therapy Wand is indicated to treat mild to moderate inflammatory acne.

## 8. Technological Characteristics and Substantial Equivalence

This document uses the term "substantial equivalence" as defined in 21 CFR 807.87 and not as defined in Title 35 of the U.S. Code.

The Acne Light Therapy Wand device is substantially equivalent to the Tanda Mini Skincare System and the LightStim for Acne devices in safety and efficacy. All are hand-held, LED light therapy wand devices indicated for the treatment of mild to moderate inflammatory acne.

The properties and characteristics of the subject and predicate devices are compared in the table below.

| Trade Name | Acne Light Therapy<br>Wand | Tanda Mini<br>Skincare System | LightStim for Acne |
|--------------------------|----------------------------|-------------------------------|--------------------|
| 510(k) Number | K160691 | K124042 | K142246 |
| Regulation<br>Number | 21CFR 878.4810 | 21CFR 878.4810 | 21CFR 878.4810 |
| Over-the-counter<br>use? | Yes | Yes | Yes |

### Table 1. Acne Light Therapy Wand vs. Tanda Mini Skincare and LightStim for Acne Systems

{5}------------------------------------------------

| Overall design | Portable battery powered device applied to the face providing LED light output. | Portable battery powered device applied to the face providing LED light output. | Mains powered hand-held device applied to the face providing LED light output. |
|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Materials | Polypropylene, Polycarbonate, Aluminum | Polypropylene, Polycarbonate | Polypropylene, Polycarbonate, |
| Wavelength | $442 \pm 4nm$<br>$633 \pm 4nm$ | $415 \pm 4nm$ | $411 \pm 4 nm$<br>$640 \pm 4 nm$ |
| Treatment Area (cm^2) | 1.594 | 4.155 | 16.6 |
| Dose Rate (mW/cm^2) | | | |
| Blue | 26.5 | 36.2 | 12.4 |
| Red | 7.5 | n/a | 6.3 |
| Total | 34.0 | 36.2 | 18.7 |
| Dose (J/cm^2) | | | |
| Blue | 9.6 | 13.0 | 8.9 |
| Red | 2.6 | n/a | 4.5 |
| Total | 12.2 | 13.0 | 13.4 |
| Performance Data | Complies with applicable performance specifications and usability requirements. | Complies with applicable performance specifications and usability requirements. | Complies with applicable performance specifications and usability requirements. |
| IEC 60601 Compliant | Yes | Yes | Yes |
| Electrical Power | 1 AAA alkaline batteries | 3 AAA alkaline batteries | AC/DC adapter |
| User Interface | On/off button,<br>located on the<br>device. Device turns<br>on with a push of the<br>button and turns off<br>automatically. There<br>are no other user<br>selectable<br>parameters. | On/off button,<br>located on the<br>device. Device turns<br>on with a push of the<br>button and turns off<br>automatically. There<br>are no other user<br>selectable<br>parameters. | On/off button,<br>located on the<br>device. Device turns<br>on/off with a push of<br>the button. There<br>are no other user<br>selectable<br>parameters. |

{6}------------------------------------------------

Texas Applied Biomedical Services (T.A.B.S.) Traditional 510(k) Premarket Submission Model: Acne Light Therapy Wand

### 9. Non-Clinical Testing

The Acne Light Therapy Wand device conforms to the requirements of IEC 60601-1 3rd edition, IEC 60601-1-2, and IEC 62471.

Additionally, a Self Selection and Usability Study was conducted with laypersons and demonstrated that the Acne Light Therapy Wand is an easy to use device and the packaging and labeling are appropriate for and easily understood by the layperson.

### 10. Clinical Testing

The Acne Light Therapy Wand is substantially equivalent to predicate devices currently in commercial distribution in the USA. Therefore, clinical testing of the device was not conducted.

### 11. Conclusion

By definition, a device is substantially equivalent to a predicate devices when the device has the same intended use and the same technological characteristics as the previously cleared predicate device. Or the device may have the same intended use and different technological characteristics if they can be demonstrated that the device is substantially equivalent to the predicate device(s), and that the new device does not raise different questions regards its safety and effectiveness as compared to the predicate device.

We have shown in this 510(k) submission that the Acne Light Therapy Wand has the same intended use and technological characteristics as the predicate devices and does not raise any questions regarding its safety and effectiveness. The Acne Light Therapy Wand device, as designed and manufactured, has been found to be substantially equivalent to the predicate devices.